Gastric Bypass and Cancer Risk: A Long-Term Perspective
Recent research suggests a potential link between gastric bypass surgery and an increased risk of adenocarcinoma, a type of cancer, in the excluded stomach. While the absolute risk remains low, a long-term study spanning decades highlights the importance of continued vigilance for individuals who have undergone this weight-loss procedure.
Understanding the Study
A population-based cohort study, encompassing data from Denmark, Finland, and Sweden, investigated the potential for gastric bypass surgery to elevate the risk of adenocarcinoma in the portion of the stomach that is bypassed during the procedure. The study followed 109,097 patients who underwent bariatric surgery, including 82,394 who had gastric bypass, for up to 44 years.1
Key Findings: Time Matters
The study revealed a notable pattern related to the timing of cancer development. While there was no increased risk of cancer within the first 9 years after surgery, the risk significantly increased between 10 and 44 years post-surgery. Specifically, patients who underwent gastric bypass had a 4.0 times higher hazard ratio (HR) for gastric non-cardia adenocarcinoma compared to those who underwent other bariatric procedures (95% Confidence Interval: 1.2-13.7).1
When compared to the general population, the standardized incidence ratio (SIR) indicated a 2.5 times higher incidence of cancer in the 10–44-year period after gastric bypass (95% CI: 1.4–5.0).1
Potential Challenges in Diagnosis
The study also suggests that diagnosing cancer in the excluded stomach may be more demanding after gastric bypass due to anatomical challenges that can hinder endoscopic access. Patients who developed non-cardia adenocarcinoma after gastric bypass appeared to have lower rates of gastrectomy (surgical removal of the stomach) and higher all-cause mortality, although these findings had wider confidence intervals and require further investigation.1
What This Means for Patients
These findings underscore the importance of long-term follow-up care for individuals who have undergone gastric bypass surgery. While the overall risk of cancer remains relatively low, awareness of this potential complication is crucial for both patients and healthcare providers. Early detection is key, and patients should be vigilant about reporting any concerning symptoms to their doctors.
Other Bariatric Surgery Options
In Sweden, approximately 5,000 obesity surgeries are performed annually.3 The two most common procedures are gastric bypass and sleeve gastrectomy (gastric sleeve). A recent study from the University of Gothenburg found that these two procedures have similar short-term complication rates.3 GB Obesitas, a specialized team in northern Europe, performs over 22,000 obesity surgeries, including gastric bypass and gastric sleeve procedures.1 Aleris Obesitas also offers both gastric bypass and sleeve gastrectomy in private settings.4
Looking Ahead
Further research is needed to fully understand the mechanisms behind this increased cancer risk and to develop strategies for improving early detection and treatment. Continued monitoring of long-term outcomes following bariatric surgery is essential to optimize patient care and ensure the best possible health outcomes.
Reference
Leijonmarck W et al. Cancer in the Excluded Stomach After Gastric Bypass Surgery for Obesity. Annals of Surgery. 2026. doi:10.1097/SLA.0000000000007035.
Related reading